Author:
Van Oorschot Desirée,McGirr Ashleigh,Goulet Philibert,Koochaki Patricia,Pratiwadi Ramya,Shah Selam,Curran Desmond
Funder
glaxosmithkline biologicals s.a.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical)
Reference25 articles.
1. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2008;57(5):1–30, https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5705a1.htm.
2. Centers for Disease Control and Prevention. About Shingles. https://www.cdc.gov/shingles/about/index.html. Accessed 11 Jul 2020.
3. Brisson M, Edmunds WJ, Law B, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001;127(2):305–14. https://doi.org/10.1017/s0950268801005921.
4. Brisson M, Pellissier JM, Camden S, Quach C, De Wals P. The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia. Hum Vaccin. 2008;4(3):238–45. https://doi.org/10.4161/hv.4.3.5686.
5. Government of Canada. Herpes Zoster (Shingles) Vaccine: Canadian immunization guide. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-8-herpes-zoster-(shingles)-vaccine.html#a2. Accessed 11 Jul 2020.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献